LungLife AI is a medical diagnostics company focused on the development of AI-supported blood-based tests for the early detection of lung cancer. It has identified a significant medical need for non-invasive, sensitive and specific tests in early-stage lung cancer. The company’s core technology, the LungLB test, seeks to detect circulating tumour cells (CTCs) to identify malignant lung nodules. It aims to apply machine learning/AI (ML/AI) to derive algorithms to increase test accuracy. Following ....
17 Jan 2022
LungLife AI - Early-stage lung cancer diagnostics
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LungLife AI - Early-stage lung cancer diagnostics
LungLife AI, Inc. (LLAI:LON) | 31.0 0 0.0% | Mkt Cap: 7.90m
- Published:
17 Jan 2022 -
Author:
Harry Shrives -
Pages:
2
LungLife AI is a medical diagnostics company focused on the development of AI-supported blood-based tests for the early detection of lung cancer. It has identified a significant medical need for non-invasive, sensitive and specific tests in early-stage lung cancer. The company’s core technology, the LungLB test, seeks to detect circulating tumour cells (CTCs) to identify malignant lung nodules. It aims to apply machine learning/AI (ML/AI) to derive algorithms to increase test accuracy. Following ....